01/22/2021
Invitation to all FHS graduate students!
Event Description:
The Medical Law IG at McMaster is pleased to present Dr. Ameet Sarpatwari, JD, PhD, Assistant Professor of Harvard Medical School and Associate Epidemiologist at the Bridgham and Woman's Hospital, who will give a guest lecture titled "The US Biosimilar Market: Progress, Challenges, and Possible Reforms" on Feb 3rd, 2020 at 7PM Eastern Time, via Zoom.
Facebook Event page: https://www.facebook.com/events/237919651246245
Zoom link: https://mcmaster.zoom.us/j/92708837777?pwd=R1o5NWRJanNWTnNNTGZCOTBWMDZUQT09
Password: 009295
Lecture Description:
In 2010, Congress passed the Biologics Price Competition and Innovation Act (BPCIA) to address high biologic prices by creating an abbreviated approval pathway for other manufacturers to start selling their own versions of originator biologics called biosimilars. However, over a decade later, the BPCIA has not yet led to vigorous price competition from biosimilars. This talk examines the role that FDA regulatory policy, patent litigation, and market dynamics have played in this stunted growth while highlighting emerging signs of progress and possible reforms to make the US biosimilars market more vibrant.